Happy Father’s Day! In this week’s Innovation Partners BioBlog, we look at how the changing world of drug prices and health care laws impact pricing. U.S. drug prices fell but may rise sharply depending on future marketplace events. New markets are open now for Paxman’s scalp cooling product, and
Special ASCO Report and Updates from Major Pharmaceutical Companies
Our focus this week is on the pharmaceutical industry with reports from the ASCO conference shaking up stocks, improving the outlook for some while downgrading others. Many companies are announcing results, cuts, and progress with key oncology drugs this week. Check out the Innovation Partners
Drug Costs in the Spotlight This Week
Drug costs are in the spotlight this week from many quarters. First, drugmakers called out by the Trump Administration for blocking generics are also included in a Kaiser Health study that found that they increased prices by double digits since 2012. The so-called ‘right to try’ bill passed the
Health Insurance Updates, New Appointments and More
Health insurance is in the news this week as insurers file their 2019 rate requests for Affordable Care Act Exchanges. The bad news: rates appear to be going up across many companies and states. The good news: The ACA appears to have helped more young women receive an earlier cancer diagnosis thanks
Healthcare and Insurance Prices in the News
Major news this week as President Trump launches “American Patients First” to bring down healthcare costs. California advanced a bill to socialize healthcare prices, while Oregon looks to reinstate its own state-based insurance exchange as ACA fees and other issue force them to seek alternatives.
A Drug that Costs $1.5 Million?
A $1.5 million drug? Yes, according to experts. The high cost of drugs is in the news this week with gene therapy for hemophilia expected to cost over $1 million, President Trump making a speech about drug prices, and indication-based pricing all making the headlines. Read on for more from this
The Cost of Cancer Treatment, Mergers and More
This week’s Innovation Partners BioBlog examines two major themes: the cost of cancer treatment, the Cigna-Express Scripts merger plans, and other top stories in healthcare. Among the topics examined in the cancer treatment category are the costs of genetics-based medicines, which are among the most
Futuristic Implant May Detect Up to Four Cancers; Addressing the Opioid Crisis and the Rising Cost of Drugs; Cigna Lawsuit and More
This week in healthcare news, we look at a new, futuristic skin implant that changes color to mimic a skin mole if it detects rising calcium levels, a potential sign of cancer. Addressing the opioid crisis is again in the news, as is the rising cost of prescription drugs. And lastly, Cigna faces